Prechemoradiotherapy Systemic Inflammation Response Index Stratifies Stage IIIB/C Non-Small-Cell Lung Cancer Patients into Three Prognostic Groups: A Propensity Score-Matching Analysis

<div>Comparative survival outcomes according to three-laddered pretreatment SIRI groups (red line: SIRI-1, IIIB and SIRI &lt; 1.9; dark blue line: SIRI-2, IIIB and SIRI ≥ 1.9 or IIIC and SIRI &lt; 1.9; and green line: SIRI-3, IIIC and SIRI ≥ 1.9): (a) progression-free survival; (b) overall survival.</div>

Journal of Oncology

fig4

Figure 4

Figure 4: Prechemoradiotherapy Systemic Inflammation Response Index Stratifies Stage IIIB/C Non-Small-Cell Lung Cancer Patients into Three Prognostic Groups: A Propensity Score-Matching Analysis 

Figure 4 | Prechemoradiotherapy Systemic Inflammation Response Index Stratifies Stage IIIB/C Non-Small-Cell Lung Cancer Patients into Three Prognostic Groups: A Propensity Score-Matching Analysis 